New contraindications and precautions have been added to the labeling of methylphenidate HCl tablets (Ritalin and Ritalin-SR, Novartis)-approved for treatment of attention deficit/hyperactivity disorder (ADHD).

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Methylphenidate-MAOI contraindication.

Newsletter